Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Int J Gynecol Cancer. 2018 Jul;28(6):1077–1084. doi: 10.1097/IGC.0000000000001271

Figure 1. Decision tree comparing neoadjuvant chemotherapy to primary debulking surgery for bulky advanced ovarian cancer.

Figure 1

The decision tree presented here describes the potential experiences of bulky AEOC patients who receive either PDS followed by ACT or NACT followed by IDS. Patients move left to right through the tree. The square node represents the decision to treat patients with PDS or NACT. Circle nodes represent the chance of a given outcome; triangle nodes represent a terminal event.

Abbreviations: AEOC, advanced epithelial ovarian cancer; PDS, primary debulking surgery; NACT, neoadjuvant chemotherapy; IDS, interval debulking surgery; ACT, adjuvant chemotherapy

*Early complications include those occurring ≤30 days post-surgery; Late complications include those occurring 1-6 months post-surgery.